Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02746445 · ClinicalTrials.gov registry record

A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT

A clinical trial of Autistic Disorder, sponsored by Wave Neuroscience.

Completed
Registry status
11
Enrollment target
1
Study location

NCT02746445 is a study of Autistic Disorder that has completed, run by Wave Neuroscience. The registered enrollment target is 11 participants, below the 113-participant average among 27 other Autistic Disorder trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02746445, a study of Autistic Disorder, has completed, sponsored by Wave Neuroscience.

COMPLETED
Registry status
11 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to continue to evaluate the long-term effectiveness of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in children with Autism Spectrum Disorder (ASD). No active MeRT treatment will be performed in this study.

Conditions Studied

Interventions

  • OTHER No intervention

Study Locations (1)

California

  • Brain Treatment Center - Newport Beach

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2016-04
Est. Completion 2017-04

Sponsor

Wave Neuroscience

11 total trials

What the Registry Record Tells You About NCT02746445

The ClinicalTrials.gov registry entry for NCT02746445 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 113-participant average among 27 other Autistic Disorder trials with a reported enrollment target (90% lower). The listed sponsor is Wave Neuroscience, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autistic Disorder appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.

NCT02746445 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02746445 about?

NCT02746445 is a clinical study titled "A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT". The purpose of this study is to continue to evaluate the long-term effectiveness of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in children with Autism Spectrum Disorder (ASD). No active MeRT treatment will be performed in this study.

What is the current status of trial NCT02746445?

This trial is currently completed. The enrollment target is 11 participants. The study started on 2016-04. Estimated completion is 2017-04.

What conditions does trial NCT02746445 study?

This clinical trial studies the following conditions: Autistic Disorder.

What interventions are being tested in trial NCT02746445?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT02746445?

This trial is sponsored by Wave Neuroscience, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02746445 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autistic Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.